Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirill Peskov

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology in Drug Development|January 3, 2024
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate BiosimilarityIgor Makarenko, Aleksandr Petrov, Bella Belova, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 1, 2020
A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human BeingsVeronika Voronova, Victor Sokolov, Amani Al-Khaifi, et al.
Plos One|February 20, 2016
Agent Based Modeling of Human Gut Microbiome Interactions and PerturbationsTatiana Shashkova, Anna Popenko, Alexander Tyakht, et al.
Journal of Lipid Research|July 12, 2019
Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemiaVictor Sokolov, Gabriel Helmlinger, Catarina Nilsson, et al.
Journal for Immunotherapy of Cancer|March 1, 2018
Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems modelYuri Kosinsky, Simon J Dovedi, Kirill Peskov, et al.
Frontiers in Pharmacology|December 15, 2022
Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology modelVeronika Voronova, Victor Sokolov, Yannick Morias, et al.
Clinical Pharmacology in Drug Development|December 20, 2024
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune ThrombocytopeniaAleksandr Petrov, Igor Makarenko, Bella Belova, et al.
Oncoimmunology|September 16, 2020
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysisBoris Shulgin, Yuri Kosinsky, Andrey Omelchenko, et al.
American Journal of Hypertension|September 11, 2023
Model-Based Assessment of the Reference Values of CAVI in Healthy Russian Population and Benchmarking With CAVI0Tatiana Safronova, Anna Kravtsova, Sergei Vavilov, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 18, 2020
Differentiating the Sodium-Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology ModelingVictor Sokolov, Tatiana Yakovleva, Lulu Chu, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology in Drug Development|January 3, 2024
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate BiosimilarityIgor Makarenko, Aleksandr Petrov, Bella Belova, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 1, 2020
A Physiology-Based Model of Bile Acid Distribution and Metabolism Under Healthy and Pathologic Conditions in Human BeingsVeronika Voronova, Victor Sokolov, Amani Al-Khaifi, et al.
Plos One|February 20, 2016
Agent Based Modeling of Human Gut Microbiome Interactions and PerturbationsTatiana Shashkova, Anna Popenko, Alexander Tyakht, et al.
Journal of Lipid Research|July 12, 2019
Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemiaVictor Sokolov, Gabriel Helmlinger, Catarina Nilsson, et al.
Journal for Immunotherapy of Cancer|March 1, 2018
Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems modelYuri Kosinsky, Simon J Dovedi, Kirill Peskov, et al.
Frontiers in Pharmacology|December 15, 2022
Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology modelVeronika Voronova, Victor Sokolov, Yannick Morias, et al.
Clinical Pharmacology in Drug Development|December 20, 2024
Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune ThrombocytopeniaAleksandr Petrov, Igor Makarenko, Bella Belova, et al.
Oncoimmunology|September 16, 2020
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysisBoris Shulgin, Yuri Kosinsky, Andrey Omelchenko, et al.
American Journal of Hypertension|September 11, 2023
Model-Based Assessment of the Reference Values of CAVI in Healthy Russian Population and Benchmarking With CAVI0Tatiana Safronova, Anna Kravtsova, Sergei Vavilov, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 18, 2020
Differentiating the Sodium-Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology ModelingVictor Sokolov, Tatiana Yakovleva, Lulu Chu, et al.
Pageof 5